Trial reportJournal of pain research2026
Buccal Acupuncture for Early Postoperative Catheter-Related Bladder Discomfort Following Ureteroscopic Lithotripsy: A Randomized, Sham-Controlled Trial.
Trial report in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation for Postoperative Pain: A Systematic Review and Meta-Analysis.Journal of pain research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate whether buccal acupuncture (BA), a minimally invasive facial acupuncture technique, reduces early postoperative catheter-related bladder discomfort (CRBD) after ureteroscopic lithotripsy (URSL). Patients and Methods: In this single-center, participant- and assessor-blinded, sham-controlled randomized trial, 118 patients undergoing URSL were randomized 1:1 to the BA group (n = 59) or sham group (n = 59). Baseline CRBD was assessed at extubation, followed by a 30-min PACU intervention. The BA group received needle insertion through guide tubes at bilateral Lower Jiao, Lumbar, and Sacral points; the sham group received identical guide-tube contact without needle penetration. The primary endpoint was moderate-to-severe CRBD (score ≥ 2) at 1 h after extubation. Secondary endpoints included CRBD at 2, 6, and 24 h, visual analog scale (VAS) pain, rescue medication use, Quality of Recovery-15 (QoR-15) and Richards-Campbell Sleep Questionnaire (RCSQ) scores on POD 1 and 2, adverse events, and participant blinding. Results: Moderate-to-severe CRBD at 1 h occurred less frequently in the BA group than in the sham group (13.6% vs. 40.7%; RR 0.33, 95% CI 0.16-0.68; Conclusion: BA reduced early postoperative moderate-to-severe CRBD and rescue medication use after URSL. BA may be a safe, non-pharmacological adjunct for acute postoperative CRBD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.